Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$32,723.13
% of Total Estimate Gain
2.07%

Blue Sky Capital Consultants Group, Inc.'s ARK Genomic Revolution ETF Holding Summary

As of 2025-03-31, Blue Sky Capital Consultants Group, Inc. held - shares of ARK Genomic Revolution ETF(ARKG), totaling N/A. This investment constitutes 0% of their stock portfolio, and Blue Sky Capital Consultants Group, Inc. now holds 0% of the outstanding ARK Genomic Revolution ETF(ARKG) stock.

The initial trade took place in 2024Q4. In addition, there have been 1 sales at an average price of $25.12 for 64,163.00 shares. Based on historical transaction data and ARKG's current price of $25.95, Blue Sky Capital Consultants Group, Inc.'s estimated gain on his ARKG holdings is $32,723.13, reflecting a 2.07% gain to date.

Blue Sky Capital Consultants Group, Inc. ARKG ($25.95) Holding Chart

Blue Sky Capital Consultants Group, Inc. ARKG ($25.95) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1